Equifax Inc.
EFXLast close · Oct 16, 2026161.25−0.01 (−0.01%)
Market cap$18.9B
11 firms' latest targets, last 90 days: median $208.00 ($148.00–$245.00), 29% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-16 | RBC Capital | $177.00 | ▼ 9% | +10% |
| 2026-10-02 | Goldman Sachs | $148.00 | ▼ 13% | -8% |
| 2026-10-02 | Barclays | $155.00 | ▼ 22% | -4% |
| 2026-09-30 | Credit Suisse | $160.00 | — | -1% |
| 2026-09-22 | Wells Fargo | $200.00 | ▼ 6% | +24% |
| 2026-09-08 | BNP Paribas Exane | $245.00 | — | +52% |
| 2026-08-21 | Rothschild & Co Redburn | $235.00 | — | +46% |
| 2026-07-22 | Deutsche Bank | $208.00 | — | +29% |
| 2026-07-22 | Needham | $245.00 | ▼ 8% | +52% |
| 2026-07-22 | Morgan Stanley | $225.00 | ▼ 8% | +40% |
| 2026-07-22 | Baird | $232.00 | ▼ 7% | +44% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $5.3B | +3% | $4.40 | -22% | est. $5.3B+0% | est. $6.65 | 17 |
| 2024reported | $5.7B | +8% | $4.84 | +10% | est. $5.7B+0% | est. $7.26 | 17 |
| 2025reported | $6.1B | +7% | $5.32 | +10% | est. $6.1B+0% | est. $7.62 | 19 |
| 2026 | $6.7B | +11% | $8.52 | +12% | $6.7B–$6.8B | $8.15–$8.66 | 18 |
| 2027 | $7.3B | +8% | $10.00 | +17% | $7.0B–$7.5B | $8.99–$10.59 | 17 |
| 2028 | $8.0B | +10% | $12.10 | +21% | $7.4B–$8.6B | $11.97–$12.21 | 14 |
| 2029 | $8.1B | +1% | $12.76 | +5% | $7.7B–$8.3B | $12.10–$13.31 | 8 |
| 2030 | $8.4B | +5% | $13.00 | +2% | $8.1B–$8.7B | $12.33–$13.56 | 12 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.